KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Receivables - Other (2016 - 2026)

Bristol Myers Squibb has reported Receivables - Other over the past 18 years, most recently at $1.4 billion for Q1 2026.

  • Quarterly Receivables - Other fell 18.18% to $1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Mar 2026, down 18.18% year-over-year, with the annual reading at $1.8 billion for FY2025, 372.99% up from the prior year.
  • Receivables - Other was $1.4 billion for Q1 2026 at Bristol Myers Squibb, down from $1.8 billion in the prior quarter.
  • Over five years, Receivables - Other peaked at $2.0 billion in Q4 2023 and troughed at $385.0 million in Q4 2024.
  • The 5-year median for Receivables - Other is $1.4 billion (2026), against an average of $1.1 billion.
  • Year-over-year, Receivables - Other crashed 81.12% in 2024 and then skyrocketed 372.99% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $504.0 million in 2022, then skyrocketed by 304.56% to $2.0 billion in 2023, then crashed by 81.12% to $385.0 million in 2024, then skyrocketed by 372.99% to $1.8 billion in 2025, then decreased by 21.91% to $1.4 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Receivables - Other are $1.4 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025).